Leptotrichia trevisanii Sepsis after Bone Marrow Transplantation

por Schrimsher, Jennifer M., McGuirk, Joseph P., Hinthorn, Daniel R.
Publicado 2013

Clinical characteristics and treatment outcome of patients with isochromosome 17q (i17q) abnormality and myeloid neoplasms: A single center experience

por Ganguly, Siddhartha, Uvodich, Mason, Dias, Ajoy, McGuirk, Joseph P.
Publicado 2018

Bendamustine Associated with Irreversible Ascending Paralysis

por Alhafez, Ashraf, Aljitawi, Omar S., Lin, Tara L., Ganguly, Siddhartha, Abhyankar, Sunil, McGuirk, Joseph P.
Publicado 2013

Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease

por McGuirk, Joseph P., Smith, J. Robert, Divine, Clint L., Zuniga, Micheal, Weiss, Mark L.
Publicado 2015

Rates of complete diagnostic testing for patients with acute myeloid leukemia

por Lin, Tara L, Williams, Travis, He, Jianghua, Aljitawi, Omar S, Ganguly, Siddhartha, Abhyankar, Sunil, Fleming, Allan, Male, Heather, McGuirk, Joseph P
Publicado 2015

CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas

por Kuravi, Sudhakiranmayi, Parrott, Elizabeth, Mudduluru, Giridhar, Cheng, Janice, Ganguly, Siddhartha, Saunthararajah, Yogen, Jensen, Roy A., Blagg, Brian S., McGuirk, Joseph P., Balusu, Ramesh
Publicado 2019

Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results

por Jaeger, Ulrich, Worel, Nina, McGuirk, Joseph P., Riedell, Peter A., Fleury, Isabelle, Du, Yan, Han, Xia, Pearson, David, Redondo, Santiago, Waller, Edmund K.
Publicado 2022

Neutralizing Antibody Responses Against Sars-Cov-2 in Patients with Plasma Cell Disorders Who Are on Active Treatment after Two Doses of mRNA Vaccination

por Abdallah, Al-Ola, Mahmoudjafari, Zahra, Mohan, Meera, McGuirk, Joseph P., Remker, Cassie, Foss, Margaret, Karloff, Ellie, Fitch, Heather, Mohyuddin, Ghulam Rehman, Atrash, Shebli
Publicado 2021

Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study

por McGuirk, Joseph P., Metheny, Leland, Pineiro, Luis, Litzow, Mark, Rowley, Scott D., Avni, Batia, Tamari, Roni, Lazarus, Hillard M., Rowe, Jacob M., Sheleg, Michal, Rothenstein, Daniel, Halevy, Nitsan, Zuckerman, Tsila
Publicado 2023

Top 100 Cited Articles on Clinical Hematopoietic Stem Cell Transplantation: A Bibliometric Analysis

por Shahzad, Moazzam, Chaudhary, Sibgha Gull, Anwar, Iqra, Arslan, Muhammad, Naseem, Zehra, Fatima, Naira T., Abbas, Sakina, Ali, Tayyaba, Siddiqui, Raheel S., Hematti, Peiman, Abhyankar, Sunil H., McGuirk, Joseph P., Mushtaq, Muhammad Umair
Publicado 2022

Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients

por Mushtaq, Muhammad Umair, Al-Ramahi, Joe S, Li, Kevin S, Shahzad, Moazzam, Chaudhary, Sibgha Gull, Balusu, Ramesh, Ahmed, Nausheen, Bansal, Rajat, Abdelhakim, Haitham, Shune, Leyla O., Singh, Anurag K., Abhyankar, Sunil H, McGuirk, Joseph P.
Publicado 2022

Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis

por Mushtaq, Muhammad Umair, Shahzad, Moazzam, Tariq, Ezza, Iqbal, Qamar, Chaudhary, Sibgha Gull, Zafar, Muhammad U., Anwar, Iqra, Ahmed, Nausheen, Bansal, Rajat, Singh, Anurag K., Abhyankar, Sunil H., Callander, Natalie S., Hematti, Peiman, McGuirk, Joseph P.
Publicado 2022

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic

por Bachanova, Veronika, Bishop, Michael R., Dahi, Parastoo, Dholaria, Bhagirathbhai, Grupp, Stephan A., Hayes-Lattin, Brandon, Janakiram, Murali, Maziarz, Richard T., McGuirk, Joseph P., Nastoupil, Loretta J., Oluwole, Olalekan O., Perales, Miguel-Angel, Porter, David L., Riedell, Peter A.
Publicado 2020

Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients

por Mushtaq, Muhammad Umair, Shahzad, Moazzam, Chaudhary, Sibgha Gull, Luder, Mary, Ahmed, Nausheen, Abdelhakim, Haitham, Bansal, Rajat, Balusu, Ramesh, DeJarnette, Shaun, Divine, Clint, Kribs, Robert, Shune, Leyla, Singh, Anurag K., Ganguly, Siddhartha, Abhyankar, Sunil H., McGuirk, Joseph P.
Publicado 2021

Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis

por Shahzad, Moazzam, Nguyen, Andrea, Hussain, Ali, Ammad-Ud-Din, Mohammad, Faisal, Muhammad Salman, Tariq, Ezza, Ali, Fatima, Butt, Atif, Anwar, Iqra, Chaudhary, Sibgha Gull, Lutfi, Forat, Ahmed, Nausheen, Singh, Anurag K., Hematti, Peiman, McGuirk, Joseph P., Mushtaq, Muhammad Umair
Publicado 2023

Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis

por Mushtaq, Muhammad Umair, Shahzad, Moazzam, Shah, Amna Y., Chaudhary, Sibgha Gull, Zafar, Muhammad U., Anwar, Iqra, Neupane, Karun, Khalid, Ayesha, Ahmed, Nausheen, Bansal, Rajat, Balusu, Ramesh, Singh, Anurag K., Abhyankar, Sunil H., Callander, Natalie S., Hematti, Peiman, McGuirk, Joseph P.
Publicado 2022

Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients

por Mushtaq, Muhammad Umair, Al-Ramahi, Joe S, Li, Kevin, Shahzad, Moazzam, Chaudhary, Sibgha Gull, Nguyen, Andrea, DeJarnette, Shaun, Lutfi, Forat, Balusu, Ramesh, Ahmed, Nausheen, Bansal, Rajat, Abdelhakim, Haitham, Shune, Leyla, Singh, Anurag K., Abhyankar, Sunil H., McGuirk, Joseph P.
Publicado 2023

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

por Wudhikarn, Kitsada, Tomas, Ana Alarcon, Flynn, Jessica R., Devlin, Sean M., Brower, Jamie, Bachanova, Veronika, Nastoupil, Loretta J., McGuirk, Joseph P., Maziarz, Richard T., Oluwole, Olalekan O., Schuster, Stephen J., Porter, David L., Bishop, Michael R., Riedell, Peter A., Perales, Miguel-Angel
Publicado 2022

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

por Bhaskar, Shakthi T., Patel, Vivek G., Porter, David L., Schuster, Stephen J., Nastoupil, Loretta J., Perales, Miguel-Angel, Tomas, Ana Alarcon, Bishop, Michael R., McGuirk, Joseph P., Maziarz, Richard T., Chen, Andy I., Bachanova, Veronika, Maakaron, Joseph E., Riedell, Peter A., Oluwole, Olalekan O.
Publicado 2022

Functional characterization of NPM1–TYK2 fusion oncogene

por Kuravi, Sudhakiranmayi, Baker, Riley W., Mushtaq, Muhammad Umair, Saadi, Irfan, Lin, Tara L., Vivian, Carolyn J., Valluripalli, Anusha, Abhyankar, Sunil, Ganguly, Siddhartha, Cui, Wei, Elenitoba-Johnson, Kojo S. J., Welch, Danny R., Jensen, Roy A., Saunthararajah, Yogen, McGuirk, Joseph P., Balusu, Ramesh
Publicado 2022